Higher rate of postoperative complications seen in DMEK

No significant difference in mean postoperative visual acuity

Higher rate of postoperative complications seen in DMEK
Dermot McGrath
Dermot McGrath
Published: Saturday, September 14, 2019
[caption id="attachment_16518" align="alignleft" width="1024"] Mor Dickman[/caption] DESCEMET Membrane Endothelial Keratoplasty (DMEK) and ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) achieved broadly similar visual outcomes but with a higher complication rate for DMEK, according to the results of a multi-centre randomised controlled trial presented at the 10th EuCornea congress. “We found no significant difference in mean postoperative visual acuity although a higher proportion of DMEK patients attained better visual acuity. The endothelial cell loss was comparable after both techniques, stabilising after three months. However, there were more complications following DMEK in terms of re-bubbling and re-grafts,” said Mor Dickman MD, PhD, University Eye Clinic, Maastricht University Medical Center, the Netherlands, who presented the study outcomes yesterday. Carried out at six clinics in the Netherlands, the prospective randomised study compared best-corrected visual acuity, endothelial cell density and complications after DMEK and UT-DSAEK in 54 eyes of 54 patients with Fuchs’ endothelial corneal dystrophy. Patients treated with DMEK experienced faster recovery of contrast sensitivity and straylight, while there was no statistical difference in total corneal aberrations or vision-related quality of life outcomes. The study concluded overall that DMEK was more costly and less effective than UT-DSAEK, and was therefore not cost-effective.
Tags: dmek, Ultrathin DSAEK
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...